Biotech Startups

Structura Biotechnology develops computational software and methods that scale cryo-EM structure determination for drug discovery and life sciences research. The company's platforms deliver high-resolution 3D protein reconstructions and real-time analysis for academic and pharmaceutical research teams.

1 investor

Stuart Therapeutics is a clinical-stage pharmaceutical company developing synthetic collagen mimetic peptides (its PolyCol platform) designed to bind and repair damaged helical collagen in the extracellular matrix. Its therapies target chronic eye diseases including dry eye disease, glaucoma, and inherited retinal disorders such as retinitis pigmentosa and age-related macular degeneration.

1 investor

Suanfarma develops, manufactures, and distributes active pharmaceutical ingredients (APIs) for the global pharmaceutical industry, serving over 400 customers across 70+ countries. The company operates as a B2B contract development and manufacturing organization (CDMO) providing end-to-end solutions for small-molecule drug substances and intermediates using fermentation and chemical synthesis.

1 investor

Succipro is a biotech spin-off from IRB CatSud and Universitat Rovira i Virgili developing first-in-class drugs that modulate succinate to treat inflammatory bowel disease and metabolic disorders. Its lead program targets inflammatory bowel disease, with additional planned indications in metabolic conditions such as metabolic dysfunction-associated fatty liver.

1 investor

SUDx-Biotec develops sugar chain-based diagnostic technologies and solutions. The company operates in the biotech sector, headquartered in Kagoshima, Japan.

1 investor

Sugarlogix develops functional food products designed to support disease management, particularly for diabetes and metabolic health, through innovative ingredients and scientific advancement in food technology.

1 investor

Sulfotools develops Clean Peptide Technology (CPT), a peptide synthesis process that replaces organic solvents with water, aimed at the pharmaceutical, chemical, and cosmetics industries. The company is a spin-off from TU Darmstadt in Germany.

1 investor

Nutrumami develops multifunctional food ingredients made from fermented faba protein (faba beans, oats, sea salt) using solid-state fermentation, delivering taste, texture, and nutrition while reducing additives and animal ingredients. Its FermiPro product line targets food manufacturers making ready meals, plant-based cheese, hybrid meat products, sauces, and snacks, and it offers co-development and waste-stream valorization services.

1 investor

Sun Bear Biofuture uses precision fermentation and biotechnology to produce naturally derived fats and oils that replace cocoa butter, palm oil, and high-value cosmetics ingredients without their environmental and supply-chain drawbacks. It serves food and cosmetics brands seeking sustainable alternatives to tropical oils.

1 investor

Sundew Bio develops fermentation-based biological products and vaccines for the aquaculture industry, leveraging synthetic biology and microbial strain engineering to address disease control and health management in fish farming.

1 investor

SunFire Bio develops and sells characterized monoclonal antibodies targeting pneumococcal polysaccharides and Shigella pathogens for research purposes. The company serves vaccine development and infectious disease research markets in the biotech sector.

1 investor

Sungwun Pharmacopia develops active pharmaceutical ingredients (APIs) and biopharmaceutical drugs, including antiviral compounds such as remdesivir and favipiravir, which it manufactures and licenses to pharmaceutical partners. The company also works on microbiome-related technology and has partnered with Indonesian pharmaceutical firm PT. Kimia Farma.

1 investor

SMPA (Sunovion) is a pharmaceutical company focused on drug discovery, development, and commercialization aimed at bringing novel medicines to patients with unmet health needs.

1 investor

Sunra Health is a pediatric health platform that gives families personalized genetic insights along with vaccine decision support, wellness forecasting, symptom tracking, and ongoing guidance from birth through childhood. It combines clinical research and technology to help parents and healthcare providers make more informed decisions about a child's health.

1 investor

Supermag manufactures magnetic levitation motors, fluid transport systems, and vacuum solutions for semiconductor, biopharmaceutical, chemical, and energy industries. The company provides high-purity, low-shear equipment designed to meet demanding manufacturing and processing requirements across multiple industrial sectors.

1 investor

Supermoon Capital is a venture investor focused on companies working in sleep and circadian science, backing scientists, technologists, and creatives building products around sleep health and biological rhythms. It targets consumer and biotech opportunities in the emerging sleep-technology market.

1 investor

Suraksha operates a network of diagnostic and healthcare centres across eastern India offering pathology, genomics, radiology and imaging, and specialty clinics, along with home sample collection and doctor consultation services. It serves patients through owned centres, public-private partnerships, and franchisees primarily in West Bengal, Bihar, Assam, and Jharkhand.

1 investor

Surfix develops diagnostic tests based on surface modification and organic chemistry technologies, offering accessible and easy-to-use solutions for early diagnosis and monitoring of medical conditions. The company operates as a spin-off from Wageningen University & Research's organic chemistry department.

1 investor

Company operating a biomarker discovery platform (Stabl) that applies multiomics, systems biology, and machine learning to extract clinically actionable biomarkers from complex datasets. Its product PreCyte SSI predicts the risk of postoperative surgical complications to help clinicians personalize perioperative care in hospitals.

1 investor

SurgiBox develops surgical technology co-developed with users to enable safe surgery for patients and healthcare providers, focused on delivering safe surgical care regardless of location. The company builds medical devices aimed at solving challenges in surgical care globally.

1 investor

Surphage develops specific bacteriophage combinations (branded NeoPhage) to control pathogenic bacteria such as Salmonella, Escherichia coli, and Listeria monocytogenes in animal and plant production without the use of antibiotics. Its powdered, easy-to-apply antimicrobial products serve the livestock, agriculture, and food-processing industries.

1 investor

SusMer develops next-generation polymers, using a proprietary chemical process to manufacture P4HB, for the medical and surgical device industry. It partners with medical device companies, contract manufacturers, material suppliers, and OEMs to qualify and characterize its material through development programs.

1 investor

Suzhou Xip Biotechnology Co., Ltd. is a Chinese biotechnology company presenting products, industry news, and investor relations information on its site. The page provides only navigation and contact details without describing specific products.

1 investor

Svastia is a clinical-genomic platform that uses genetic screening to improve cancer therapy outcomes for pharmaceutical companies and hospitals. The platform bundles contract research services with bioinformatics analysis, and coordinates a distributed network of laboratory service providers to support drug development, clinical trial patient selection, and personalized treatment recommendations.

1 investor